» Articles » PMID: 21483568

Allergen-specific Subcutaneous Immunotherapy in Allergic Asthma: Immunologic Mechanisms and Improvement

Overview
Journal Libyan J Med
Specialty General Medicine
Date 2011 Apr 13
PMID 21483568
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Allergic asthma is a disease characterized by persistent allergen-driven airway inflammation, remodeling, and airway hyperresponsiveness. CD4(+) T-cells, especially T-helper type 2 cells, play a critical role in orchestrating the disease process through the release of the cytokines IL-4, IL-5, and IL-13. Allergen-specific immunotherapy (SIT) is currently the only treatment with a long-term effect via modifying the natural course of allergy by interfering with the underlying immunological mechanisms. However, although SIT is effective in allergic rhinitis and insect venom allergy, in allergic asthma it seldom results in complete alleviation of the symptoms. Improvement of SIT is needed to enhance its efficacy in asthmatic patients. Herein, the immunoregulatory mechanisms underlying the beneficial effects of SIT are discussed with the ultimate aim to improve its treatment efficacy.

Citing Articles

Intratonsillar Immunotherapy: A Convenient and Effective Alternative to Subcutaneous Immunotherapy for Allergic Rhinitis.

Gu T, Zhang W, Tan L, Xiang R, Liu P, Huang J Research (Wash D C). 2025; 8():0573.

PMID: 39822282 PMC: 11735709. DOI: 10.34133/research.0573.


Effectiveness of Indonesian house dust mite allergenic extract in triggering allergic rhinitis sensitivity in a mouse model: A preliminary study.

Pratama Y, Dinina F, Nurhan A, Sari W, Ardianto C, Khotib J Vet World. 2022; 15(9):2333-2341.

PMID: 36341054 PMC: 9631360. DOI: 10.14202/vetworld.2022.2333-2341.


Ameliorative Effect of Imperatorin on -Induced Allergic Asthma by Suppressing the Th2 Response in Mice.

Hsieh C, Ng Y, Li W, Tzeng C, Hsu T, Huang W Molecules. 2022; 27(20).

PMID: 36296620 PMC: 9610181. DOI: 10.3390/molecules27207028.


Targeted deletion of Interleukin-3 results in asthma exacerbations.

Kolle J, Zimmermann T, Kiefer A, Rieker R, Xepapadaki P, Zundler S iScience. 2022; 25(6):104440.

PMID: 35707726 PMC: 9189047. DOI: 10.1016/j.isci.2022.104440.


An Immunoregulatory Role of Interleukin-3 in Allergic Asthma.

Krammer S, Yang Z, Zimmermann T, Xepapadaki P, Geppert C, Papadopoulos N Front Immunol. 2022; 13:821658.

PMID: 35281014 PMC: 8904351. DOI: 10.3389/fimmu.2022.821658.


References
1.
Munn D, Sharma M, Lee J, Jhaver K, Johnson T, Keskin D . Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002; 297(5588):1867-70. DOI: 10.1126/science.1073514. View

2.
Mekala D, Alli R, Geiger T . IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc Natl Acad Sci U S A. 2005; 102(33):11817-22. PMC: 1188008. DOI: 10.1073/pnas.0505445102. View

3.
Belladonna M, Grohmann U, Guidetti P, Volpi C, Bianchi R, Fioretti M . Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol. 2006; 177(1):130-7. DOI: 10.4049/jimmunol.177.1.130. View

4.
Hagenbaugh A, Sharma S, Dubinett S, Wei S, Aranda R, Cheroutre H . Altered immune responses in interleukin 10 transgenic mice. J Exp Med. 1997; 185(12):2101-10. PMC: 2196349. DOI: 10.1084/jem.185.12.2101. View

5.
Cookson W . Asthma genetics. Chest. 2002; 121(3 Suppl):7S-13S. DOI: 10.1378/chest.121.3_suppl.7s-a. View